Warfarin & APS

A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

Original Article from The New England Journal of Medicine — A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
nejm.org

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

Journal of Thrombosis and Haemostasis Explore this journal > Explore this journal > Previous article in issue: Cell-derived microparticles: ‘Miniature envoys with many faces’ Previous article in issue: Cell-derived microparticles: ‘Miniature envoys with many faces’ Next article in issue: The influen…
onlinelibrary.wiley.com

Controversies in the antiphospholipid syndrome: can we ever stop warfarin?

Patients with antiphospholipid syndrome are at increased risk for recurrent arterial and venous…
jautoimdis.biomedcentral.com